Skip to main content
NCBI home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1983 Dec;46(12):1134–1137. doi: 10.1136/jnnp.46.12.1134

Twenty-four hour plasma levels of growth hormone and prolactin in Huntington's disease.

R Durso, C A Tamminga, S Ruggeri, A Denaro, S Kuo, T N Chase
PMCID: PMC491780  PMID: 6229607

Abstract

Since hypothalamic neural degeneration is thought to occur in individuals with Huntington's disease, anterior pituitary hormone secretion which is in part regulated by the hypothalamus, was postulated to be altered in patients with this disease. To test this proposal, nine females with Huntington's disease were matched with controls to participate in a 24-hour basal level study of growth hormone and prolactin concentration in plasma. Patients who were free from all centrally active medication for at least six months and normal volunteers had blood sampled at 30-minute intervals over 24 hours in a minimal stress environment. The results demonstrated that plasma levels of growth hormone were elevated throughout the 24-hour time period in Huntington's disease individuals. Despite the elevation, the mean growth hormone curve of the Huntington's disease group retained characteristics similar to the control curve throughout the 24-hour time. Basal 24-hour plasma prolactin concentrations in Huntington's disease patients showed no difference from those in control individuals.

Full text

PDF
1134

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brazeau P., Vale W., Burgus R., Ling N., Butcher M., Rivier J., Guillemin R. Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science. 1973 Jan 5;179(4068):77–79. doi: 10.1126/science.179.4068.77. [DOI] [PubMed] [Google Scholar]
  2. Caine E., Kartzinel R., Ebert M., Carter A. C. Neuroendocrine function in Huntington's disease: dopaminergic regulation of prolactin release. Life Sci. 1978 Mar;22(10):911–918. doi: 10.1016/0024-3205(78)90616-1. [DOI] [PubMed] [Google Scholar]
  3. Caraceni T., Panerai A. E., Paratl E. A., Cocchi D., Müller E. E. Altered growth hormone and prolactin responses to dopaminergic stimulation in Huntington's chorea. J Clin Endocrinol Metab. 1977 May;44(5):870–875. doi: 10.1210/jcem-44-5-870. [DOI] [PubMed] [Google Scholar]
  4. Chalmers R. J., Johnson R. H., Keogh H. J., Nanda R. N. Growth hormone and prolactin response to bromocriptine in patients with Huntington's chorea. J Neurol Neurosurg Psychiatry. 1978 Feb;41(2):135–139. doi: 10.1136/jnnp.41.2.135. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Cramer H., Kohler J., Oepen G., Schomburg G., Schröter E. Huntington's chorea-- measurements of somatostatin, substance P and cyclic nucleotides in the cerebrospinal fluid. J Neurol. 1981;225(3):183–187. doi: 10.1007/BF00313747. [DOI] [PubMed] [Google Scholar]
  6. Eden S., Eriksson E., Martin J. B., Modigh K. Evidence for a growth hormone releasing factor mediating alpha-adrenergic influence on growth hormone secretion in the rat. Neuroendocrinology. 1981 Jul;33(1):24–27. doi: 10.1159/000123196. [DOI] [PubMed] [Google Scholar]
  7. Ferland L., Labrie F., Jobin M., Arimura A., Schally A. V. Physiological role of somatostatin in the control of growth hormone and thyrotropin secretion. Biochem Biophys Res Commun. 1976 Jan 12;68(1):149–156. doi: 10.1016/0006-291x(76)90022-x. [DOI] [PubMed] [Google Scholar]
  8. Hayden M. R., Vinik A. I., Paul M., Beighton P. Impaired prolactin release in Huntington's chorea. Evidence for dopaminergic excess. Lancet. 1977 Aug 27;2(8035):423–426. doi: 10.1016/s0140-6736(77)90608-0. [DOI] [PubMed] [Google Scholar]
  9. Keogh H. J., Johnson R. H., Nanda R. N., Sulaiman W. R. Altered growth hormone release in Huntington's chorea. J Neurol Neurosurg Psychiatry. 1976 Mar;39(3):244–248. doi: 10.1136/jnnp.39.3.244. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Levy C. L., Carlson H. E., Sowers J. R., Goodlett R. E., Tourtellotte W. W., Hershman J. M. Growth hormone and prolactin secretion in Huntington's disease. Life Sci. 1979 Feb 19;24(8):743–749. doi: 10.1016/0024-3205(79)90357-6. [DOI] [PubMed] [Google Scholar]
  11. Murri L., Iudice A., Muratorio A., Polleri A., Barreca T., Murialdo G. Spontaneous nocturnal plasma prolactin and growth hormone secretion in patients with Parkinson's disease and Huntington's chorea. Eur Neurol. 1980;19(3):198–206. doi: 10.1159/000115147. [DOI] [PubMed] [Google Scholar]
  12. Müller E. E., Parati E. A., Panerai A. E., Cocchi D., Caraceni T. Growth hormone hyperresponsiveness to dopaminergic stimulation in Huntington's chorea. Neuroendocrinology. 1979;28(5):313–319. doi: 10.1159/000122878. [DOI] [PubMed] [Google Scholar]
  13. Phillipson O. T., Bird E. D. Plasma growth hormone concentrations in Huntington's chorea. Clin Sci Mol Med. 1976 Jun;50(6):551–554. doi: 10.1042/cs0500551. [DOI] [PubMed] [Google Scholar]
  14. Podolsky S., Leopold N. A. Growth hormone abnormalities in Huntington's chorea: effect of L-dopa administration. J Clin Endocrinol Metab. 1974 Jul;39(1):36–39. doi: 10.1210/jcem-39-1-36. [DOI] [PubMed] [Google Scholar]
  15. Polleri A., Savoldi F., Muratorio A., Masturzo P., Murialdo G., Martignoni E., Nappi G., Iudice A., Murri L. Circadian rhythmicity of prolactin secretion in Huntington's chorea. Life Sci. 1980 May 12;26(19):1609–1617. doi: 10.1016/0024-3205(80)90364-1. [DOI] [PubMed] [Google Scholar]
  16. VOGT C., VOGT O. Precipitating and modifying agents in chorea. J Nerv Ment Dis. 1952 Dec;116(6):601–607. doi: 10.1097/00005053-195212000-00015. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES